RECENT NEWS

Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration MORE >

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells MORE >

Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell MORE >

Pascal Biosciences Acquires Technology to Treat Leukemia from the University of New Mexico MORE >

Pascal Biosciences Creates Development Science Lab in Seattle, WA MORE >

bioMmune Announces Name Change to Pascal Biosciences Inc. MORE >

bioMmune Announces Adoption of Advance Notice Policy MORE >

bioMmune Technology Inc. Grants Stock Options MORE >